St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
591 hedge funds and large institutions have $16.1B invested in St Jude Medical in 2014 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 187 increasing their positions, 229 reducing their positions, and 43 closing their positions.
181% more call options, than puts
Call options by funds: $172M | Put options by funds: $61M
84% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 43
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
5% more capital invested
Capital invested by funds: $15.3B → $16.1B (+$804M)
5% more funds holding
Funds holding: 563 → 591 (+28)
18% less repeat investments, than reductions
Existing positions increased: 187 | Existing positions reduced: 229
Top Buyers
Top Sellers
STJ Hedge Fund Activity: Q4 2014 in Review
591 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2014, worth a combined $16.1B — up 5.3% from $15.3B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new STJ positions and 43 closed out — a net gain of 36 holders — while 187 added to existing stakes and 229 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $181M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $699M sold.
- 591 institutional investors held St Jude Medical (STJ) as of Q4 2014, up from 563 in Q3 2014.
- Funds reported $16.1B of St Jude Medical stock for Q4 2014, up 5.3% quarter-over-quarter.
- 79 funds opened new St Jude Medical positions in Q4 2014 and 43 closed out, a net change of +36 holders.
- The largest St Jude Medical buyer in Q4 2014 was Capital Research Global Investors, an estimated $181M added.
- The largest St Jude Medical seller in Q4 2014 was Americafirst Capital Management, an estimated $699M sold.
Based on aggregated 13F filings for Q4 2014.